These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 34372542)

  • 1. Adeno-Associated Virus (AAV) Gene Delivery: Dissecting Molecular Interactions upon Cell Entry.
    Large EE; Silveria MA; Zane GM; Weerakoon O; Chapman MS
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adeno-Associated Virus Engineering and Load Strategy for Tropism Modification, Immune Evasion and Enhanced Transgene Expression.
    Zhou X; Liu J; Xiao S; Liang X; Li Y; Mo F; Xin X; Yang Y; Gao C
    Int J Nanomedicine; 2024; 19():7691-7708. PubMed ID: 39099791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivering Transgenic DNA Exceeding the Carrying Capacity of AAV Vectors.
    Hirsch ML; Wolf SJ; Samulski RJ
    Methods Mol Biol; 2016; 1382():21-39. PubMed ID: 26611576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors.
    Shi W; Arnold GS; Bartlett JS
    Hum Gene Ther; 2001 Sep; 12(14):1697-711. PubMed ID: 11560765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tracking Adeno-Associated Virus Capsid Evolution by High-Throughput Sequencing.
    de Alencastro G; Pekrun K; Valdmanis P; Tiffany M; Xu J; Kay MA
    Hum Gene Ther; 2020 May; 31(9-10):553-564. PubMed ID: 32024384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and Validation of Small Molecules That Enhance Recombinant Adeno-associated Virus Transduction following High-Throughput Screens.
    Nicolson SC; Li C; Hirsch ML; Setola V; Samulski RJ
    J Virol; 2016 Aug; 90(16):7019-7031. PubMed ID: 27147738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engagement of the B-cell antigen receptor (BCR) allows efficient transduction of ZAP-70-positive primary B-CLL cells by recombinant adeno-associated virus (rAAV) vectors.
    Kofler DM; Büning H; Mayr C; Bund D; Baumert J; Hallek M; Wendtner CM
    Gene Ther; 2004 Sep; 11(18):1416-24. PubMed ID: 15269708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and cellular biology of adeno-associated virus attachment and entry.
    Zengel J; Carette JE
    Adv Virus Res; 2020; 106():39-84. PubMed ID: 32327148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Alternate Route for Adeno-associated Virus (AAV) Entry Independent of AAV Receptor.
    Dudek AM; Pillay S; Puschnik AS; Nagamine CM; Cheng F; Qiu J; Carette JE; Vandenberghe LH
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29343568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparan Sulfate Binding Promotes Accumulation of Intravitreally Delivered Adeno-associated Viral Vectors at the Retina for Enhanced Transduction but Weakly Influences Tropism.
    Woodard KT; Liang KJ; Bennett WC; Samulski RJ
    J Virol; 2016 Nov; 90(21):9878-9888. PubMed ID: 27558418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular trafficking of adeno-associated viral vectors.
    Ding W; Zhang L; Yan Z; Engelhardt JF
    Gene Ther; 2005 Jun; 12(11):873-80. PubMed ID: 15829993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant adeno-associated virus type 2 replication and packaging is entirely supported by a herpes simplex virus type 1 amplicon expressing Rep and Cap.
    Conway JE; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
    J Virol; 1997 Nov; 71(11):8780-9. PubMed ID: 9343238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vitro Evaluation of AAV Vectors for Retinal Gene Therapy.
    Wagner JE; Schön C; Becirovic E; Biel M; Michalakis S
    Methods Mol Biol; 2019; 1834():383-390. PubMed ID: 30324456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Context-Specific Function of the Engineered Peptide Domain of PHP.B.
    Martino RA; Fluck EC; Murphy J; Wang Q; Hoff H; Pumroy RA; Lee CY; Sims JJ; Roy S; Moiseenkova-Bell VY; Wilson JM
    J Virol; 2021 Sep; 95(20):e0116421. PubMed ID: 34346767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular transport of recombinant adeno-associated virus vectors.
    Nonnenmacher M; Weber T
    Gene Ther; 2012 Jun; 19(6):649-58. PubMed ID: 22357511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bound Protein- and Peptide-Based Strategies for Adeno-Associated Virus Vector-Mediated Gene Therapy: Where Do We Stand Now?
    Zhang X; Chai Z; Samulski RJ; Li C
    Hum Gene Ther; 2020 Nov; 31(21-22):1146-1154. PubMed ID: 32940063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant adeno-associated virus-mediated high-efficiency, transient expression of the murine cationic amino acid transporter (ecotropic retroviral receptor) permits stable transduction of human HeLa cells by ecotropic retroviral vectors.
    Bertran J; Miller JL; Yang Y; Fenimore-Justman A; Rueda F; Vanin EF; Nienhuis AW
    J Virol; 1996 Oct; 70(10):6759-66. PubMed ID: 8794313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Custom adeno-associated virus capsids: the next generation of recombinant vectors with novel tropism.
    Muzyczka N; Warrington KH
    Hum Gene Ther; 2005 Apr; 16(4):408-16. PubMed ID: 15871672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant adeno-associated virus vectors for gene therapy.
    Conlon TJ; Flotte TR
    Expert Opin Biol Ther; 2004 Jul; 4(7):1093-101. PubMed ID: 15268676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of capsid modifications by selected peptide ligands on recombinant adeno-associated virus serotype 2-mediated gene transduction.
    Naumer M; Popa-Wagner R; Kleinschmidt JA
    J Gen Virol; 2012 Oct; 93(Pt 10):2131-2141. PubMed ID: 22764318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.